Bioxyne Ltd has released a press release.
Quarterly Activities Report December 2024 Revised
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Bioxyne
- Revenue Guidance
- Addendum to Presentation dated 18 November 2024
- Response to ASX Price Query
- Investor Presentation November 2024
- Bioxyne Extends Contract with Aura Therapeutics
Later from Bioxyne
- BXN H1 FY25 Results Presentation
- Pause in Trading
- Trading Halt
- Bioxyne Raises A$3 million in Capital Raise
- BXN Signs Exclusive $7m Manufacturing and Supply Agreement
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne